Zoetis Inc. (NYSE:ZTS) Shares Acquired by Vaughan Nelson Investment Management L.P.

Vaughan Nelson Investment Management L.P. raised its position in Zoetis Inc. (NYSE:ZTS) by 5.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,369,751 shares of the company’s stock after acquiring an additional 75,431 shares during the quarter. Zoetis makes up approximately 2.2% of Vaughan Nelson Investment Management L.P.’s portfolio, making the stock its 8th biggest position. Vaughan Nelson Investment Management L.P. owned 0.30% of Zoetis worth $237,461,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Webster Bank N. A. increased its position in Zoetis by 89.1% in the 1st quarter. Webster Bank N. A. now owns 174 shares of the company’s stock worth $29,000 after purchasing an additional 82 shares during the last quarter. Private Wealth Management Group LLC acquired a new position in shares of Zoetis during the 4th quarter worth about $33,000. Gladius Capital Management LP bought a new position in shares of Zoetis during the fourth quarter worth approximately $40,000. Neo Ivy Capital Management acquired a new stake in Zoetis during the fourth quarter worth about $40,000. Finally, LRI Investments LLC bought a new stake in shares of Zoetis during the first quarter worth $43,000. 92.80% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on ZTS shares. The Goldman Sachs Group lowered their price objective on Zoetis from $223.00 to $196.00 and set a “buy” rating on the stock in a research report on Monday, May 6th. Stifel Nicolaus upped their target price on shares of Zoetis from $180.00 to $200.00 and gave the stock a “buy” rating in a research report on Monday, August 5th. Piper Sandler boosted their price target on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday. BTIG Research raised their price objective on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a report on Monday, August 12th. Finally, Barclays lowered their target price on Zoetis from $260.00 to $230.00 and set an “overweight” rating on the stock in a report on Tuesday, April 23rd. Nine equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Zoetis has a consensus rating of “Buy” and a consensus target price of $217.11.

Zoetis Price Performance

Shares of Zoetis stock traded down $0.37 during trading hours on Friday, reaching $183.71. The stock had a trading volume of 1,588,375 shares, compared to its average volume of 2,759,420. The stock’s 50 day moving average is $177.78 and its 200 day moving average is $175.20. The firm has a market capitalization of $83.83 billion, a PE ratio of 35.40, a PEG ratio of 2.81 and a beta of 0.86. The company has a current ratio of 3.45, a quick ratio of 2.09 and a debt-to-equity ratio of 1.32. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $201.92.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.49 by $0.07. The firm had revenue of $2.36 billion for the quarter, compared to analysts’ expectations of $2.31 billion. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. The firm’s revenue was up 8.3% compared to the same quarter last year. During the same period last year, the firm earned $1.41 EPS. Equities analysts expect that Zoetis Inc. will post 5.84 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 4th. Shareholders of record on Thursday, July 18th will be paid a $0.432 dividend. This represents a $1.73 annualized dividend and a yield of 0.94%. The ex-dividend date of this dividend is Thursday, July 18th. Zoetis’s dividend payout ratio is currently 33.14%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.